Perioperative Pharmaceutical Franchise Dedicated to Ophthalmology
Mobius Therapeutics is dedicated to developing sterile injectable pharmaceuticals optimized for ophthalmic applications. With a deep pipeline of products under development, we at Mobius continue our mission of improving the convenience, safety and integrity of perioperative pharmaceuticals by seeking innovative methods of delivery on our mission to be your one-stop shop for FDA approved peri-operative drugs.
Mitosol, finally a Mitomycin that has it all! The only FDA-approved formulation of ophthalmic MMC.
(hyaluronidase injection, USP)
150 USP units/mL
Using Hylenex® or Vitrase®? SAVE MONEY by switching to Amphadase®. 2-year shelf life & single dose vials, 150 USP units/mL.
Amphadase® is a registered trademark of Amphastar Pharmaceuticals, Inc., Hylenex® is a registered trademark of Halozyme, Inc.
Vitrase® is a registered trademark of ISTA Pharmaceuticals, Inc.
WMT-002 Rev 07/2022